+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Nitro Compounds 328546-65-2
328546-65-2,MFCD04973407
Catalog No.:AA007IMM

328546-65-2 | 9-Nitro-1,2,3,4-tetrahydro-5h-1,4-benzodiazepin-5-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
≥ 99 % (HPLC)
2 weeks  
$390.00   $273.00
- +
250mg
≥ 99 % (HPLC)
2 weeks  
$685.00   $480.00
- +
1g
≥ 99 % (HPLC)
2 weeks  
$1,264.00   $885.00
- +
2g
95+%
2 weeks  
$1,923.00   $1,346.00
- +
5g
95+%
2 weeks  
$2,558.00   $1,791.00
- +
10g
95+%
2 weeks  
$3,550.00   $2,485.00
- +
25g
95+%
2 weeks  
$4,898.00   $3,429.00
- +
50g
95+%
2 weeks  
$6,801.00   $4,761.00
- +
100g
95+%
2 weeks  
$9,527.00   $6,669.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007IMM
Chemical Name:
9-Nitro-1,2,3,4-tetrahydro-5h-1,4-benzodiazepin-5-one
CAS Number:
328546-65-2
Molecular Formula:
C9H9N3O3
Molecular Weight:
207.1861
MDL Number:
MFCD04973407
SMILES:
O=C1NCCNc2c1cccc2[N+](=O)[O-]
Properties
Computed Properties
 
Complexity:
276  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
XLogP3:
0.8  

Downstream Synthesis Route

[1]JournalofMedicinalChemistry,2003,vol.46,p.210-213

[1]BioorganicandMedicinalChemistry,2003,vol.11,p.3695-3707

[2]Patent:WO2008/51547,2008,A1.Locationinpatent:Page/Pagecolumn565

[1]Skalitzky,DonaldJ.;Marakovits,JosephT.;Maegley,KarenA.;Ekker,Anne;Yu,Xiao-Hong;Hostomsky,Zdenek;Webber,StephenE.;Eastman,BrianW.;Almassy,Robert;Li,Jianke;Curtin,NicolaJ.;Newell,DavidR.;Calvert,A.Hilary;Griffin,RogerJ.;Golding,BernardT.[JournalofMedicinalChemistry,2003,vol.46,#2,p.210-213]

[1]Patent:US6548494,2003,B1

[1]Patent:US5270464,1993,A

Literature

Title: Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries.

Journal: Bioorganic & medicinal chemistry 20030815

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 328546-65-2
Building Blocks
More >
Tags:328546-65-2 Molecular Formula|328546-65-2 MDL|328546-65-2 SMILES|328546-65-2 9-Nitro-1,2,3,4-tetrahydro-5h-1,4-benzodiazepin-5-one